Detalhe da pesquisa
1.
Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.
Eur J Clin Pharmacol;
75(8): 1135-1141, 2019 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30918988
2.
Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.
Eur J Clin Pharmacol;
75(9): 1331, 2019 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31254013
3.
Genome-wide association study identifies novel breast cancer susceptibility loci.
Nature;
447(7148): 1087-93, 2007 Jun 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17529967
4.
FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
Hum Mol Genet;
18(9): 1692-703, 2009 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19223389
5.
No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families.
Breast Cancer Res Treat;
125(1): 169-73, 2011 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20458532
6.
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
Am J Hum Genet;
81(6): 1186-200, 2007 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17999359
7.
Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists.
Breast Cancer Res Treat;
118(1): 177-84, 2009 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19214745
8.
Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan.
Radiat Res;
171(1): 77-88, 2009 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19138047
9.
Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists.
Int J Cancer;
122(1): 177-82, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17764108
10.
Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists.
Cancer Epidemiol Biomarkers Prev;
17(8): 2007-11, 2008 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18708391
11.
Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.
Eur J Med Genet;
51(2): 141-7, 2008.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18158280
12.
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping.
BMC Genet;
9: 14, 2008 Feb 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18251999
13.
Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States.
JCO Precis Oncol;
22018 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35135159
14.
SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.
J Allergy Clin Immunol Pract;
6(1): 38-69, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29310768
15.
Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologists.
Cancer Epidemiol Biomarkers Prev;
16(1): 174-7, 2007 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17220349
16.
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
Cancer Epidemiol Biomarkers Prev;
16(7): 1416-21, 2007 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17627006
17.
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies.
BMC Genet;
8: 68, 2007 Oct 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17916242
18.
The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.
Hum Mutat;
27(6): 538-44, 2006 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16652348
19.
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.
J Clin Oncol;
23(34): 8629-35, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16314625
20.
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer Epidemiol Biomarkers Prev;
15(1): 76-9, 2006 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16434590